A new surgical method of treating patients with unstable insulin-dependent diabetes (IDD) has been developed-that of surgically shunting pancreatic blood into the systemic blood flow with the purpose of creating a more optimal interaction of subcutaneously administered insulin and pancreas-secreted glucagon.
INTRODUCTION
It is common knowledge that the basis of the pathogenesis of insulin-dependent diabetes (IDD) is insufficiency of insulin. The role of insulin antagonists, glucagon among them, in disturbances of glucose metabolism still remains unclear. Some reports indicate that glucagon enhances glucose production by the liver, and that its secretion in the pancreas of IDD patients increases 1-4. Moreover, it has been demonstrated that Correspondence to: *Professor E.I. Galperin, 39 Bolshaya Gruzinskays Street, ap. 45, 123056 Moscow, Russia. Tel. (095) 118-82-38 also enhanced in IDD patients is the function of the contrinsular hormones of the adrenal glands 1.
Glucose homeostasis is maintained by the production of glucose in the liver and its utilization by peripheral tissues; it is controlled by the interaction of insulin and anti-insulin hormones. Exogenous insulin is injected into IDD patients subcutaneously, with only part of it reaching the liver where-as all the endogenously secreted glucagon enters the liver via the splenic and portal veins. The lack of correlation of the injected insulin with endogenous glucagon in the tissues may be one of the causes of the insufficient effect of insulin therapy.
Experimental research we carried out earlier in two diabetes mellitus models in dogs (subtotal resection of the pancreas and alloxan administration) demon-192 3 (the difference between the groups by the x criterion is statistically significant, p < 0.001).
Before surgery hypoglycemia occurred in 110 patients. After surgery 54 patients with patent anastomoses stopped complaining of hypoglycemia, in 27 it occurred seldom, and in only 11 patients the operation produced no improvement. Out of the 18 patients with impassable anastomoses 10 had postoperatively the same complaints, in 6 the hypoglycemia states were more easily tolerated, and in only 2 patients hypoglycemia disappeared (the difference between the groups by the x criterion is statistically significant, p < 0.001).
DISCUSSION
Changes in the blood discharged from hormoneproducing organs (pancreas and adrenal glands) is used in metabolic surgery to improve the patients' status in glucagon storage disease , hereditary hyperlipedemial, some forms of hypertension2, and chronic hepatitis3. In these cases the liver, as the chief organ of hormone metabolization, is eitherincluded in2'13', or excluded from ' the blood flow.
The liver is the chief organ for the metabolism of pancreatic hormones, determining glucose homeostasis. Experiments on diabetes mellitus models show that in the case of disturbances of insulin secretion the liver's glucose production increases and is not blocked by the administration of glucose4. One of the causes might be increased glucagon secretion. Also important is insulin degradation in the liver15, which lowers the content in the systemic blood. There are some things which we are still unable to explain, but which we believe warrant attention. Observed in patients with patent anastomoses was a rise of the c-peptide level on an empty stomach. Whether this results from the improved functioning of the pancreas or is a response to stimulation by endogenous glucagon, which postoperatively affects the beta-cells of the pancreas via the systemic blood flow, is not clear.
Of certain interest is glucagon's interaction with adrenal hormones, which also possess a contrainsular action and play an important role in the regulation of vascular tone and microcirculation. Increased secretion by the adrenal glands of contrainsular hormones in diabetics is regarded as a response to metabolic stress, which during the long term course of diabetes gets transformed into an injury mechanism, promoting the development of microangiopathyTM. Glucagon and the contrainsular hormones of the adrenals are to a large extent synergists, providing the body with metabolic substrates1. At the same time, in distinction to the adrenal hormones, glucagon does not produce a vasospastic effect. As our studies have shown (see Table 1 ), extrahepatic shunting of glucagon into the systemic bloodflow is accompanied by a diminution of the cortisol level. Further investigations will clarify whether these changes are regular, and establish their role in altering the microcirculation.
An analysis of the findings presented in this paper convincingly points to the dependence of surgical results on the patency of the created splenorenal anastomosis. The chief result of the operation is stabilisation of the diabetic course.
